Daru-Journal of Pharmaceutical Sciences
Leading citation impact metric from Clarivate Journal Citation Reports
papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 1.50đ | WoS Q3(IF: 2.8) | 🔵 Computed |
| 2025 | 1.50đ | WoS Q3(IF: 2.1) | 🔵 Computed |
| 2023 | 1.50đ | WoS Q3(IF: 3.6) | 🔵 Computed |
| 2022 | 1.50đ | WoS Q3(IF: 4.088) | 🔵 Computed |
| 2021 | 1.50đ | WoS Q3(IF: 3.117) | 🔵 Computed |
| 2020 | 1.50đ | WoS Q3(IF: 2.739) | 🔵 Computed |
| 2019 | 1.50đ | WoS Q3(IF: 2.698) | 🔵 Computed |
| 2018 | 1.50đ | WoS Q3(IF: 2.667) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
DARU Journal of Pharmaceutical Sciences is a peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment. The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.
SCImago & Scopus Journal Intelligence
Not indexed in SCImago / Scopus databaseThis journal is currently not indexed in Scopus or is an academic publication indexed exclusively in Web of Science (WoS).
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
PHARMACOLOGY & PHARMACY | JCRSCIE | 181/356 | Q3 |
PHARMACOLOGY & PHARMACY | JCISCIE | 191/356 | Q3 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2025 | 2.1 | — | — |
| 2023 | 3.6 | — | — |
| 2022 | 4.088 | — | — |
| 2021 | 3.117 | — | — |
| 2020 | 2.739 | — | — |
| 2019 | 2.698 | — | — |
| 2018 | 2.667 | — | — |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Daru-Journal of Pharmaceutical Sciences
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics